Department of Obstetrics and Gynecology, School of Medicine, The University of North Carolina at Chapel Hill, Asheville, North Carolina, USA.
Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
J Womens Health (Larchmt). 2022 Mar;31(3):331-340. doi: 10.1089/jwh.2021.0220. Epub 2021 Dec 17.
One key strategy to reduce maternal morbidity and mortality involves optimizing prepregnancy health. Although nine core indicators of preconception wellness (PCW) have been proposed by clinical experts, few studies have attempted to assess the preconception health status of a population using these indicators. We conducted a retrospective chart review study of patients who received prenatal or primary care, identified by pregnancy-related ICD-10 codes, at either of two health systems in geographically and socioeconomically different areas of North Carolina between October 1, 2015, and September 30, 2018. Our primary study aim was to determine the feasibility of measuring the proposed PCW indicators through retrospective review of prenatal electronic health records at these two institutions. Data were collected from 15,384 patients at Site 1 and 6,983 patients at Site 2. The indicators most likely to be documented and to meet the preconception health goal at each site were avoidance of teratogenic medications (98.8% and 98.3% at Sites 1 and 2, respectively) and entry to care in the first trimester (64.5% and 73.5% at Sites 1 and 2, respectively), whereas our measures of folic acid use, depression screening, and discussion of family planning were documented less than 20% of the time at both sites. Differences in measuring and documenting PCW indicators across the two health systems in our study presented barriers to monitoring and optimizing PCW. Efforts to address health and wellness before pregnancy will likely require health systems and payors to standardize, incorporate, and promote preconception health indicators that can be consistently measured and analyzed across health systems.
降低孕产妇发病率和死亡率的一个关键策略是优化备孕健康状况。尽管临床专家提出了九个核心孕前健康指标(PCW),但很少有研究试图使用这些指标来评估人群的孕前健康状况。我们对 2015 年 10 月 1 日至 2018 年 9 月 30 日期间在北卡罗来纳州两个地理位置和社会经济状况不同地区的两个医疗保健系统接受产前或初级保健的患者进行了回顾性图表审查研究,这些患者通过妊娠相关的 ICD-10 代码确定。我们的主要研究目的是确定通过对这两个机构的产前电子健康记录进行回顾性审查来衡量拟议的 PCW 指标的可行性。在 Site1 收集了 15384 名患者的数据,在 Site2 收集了 6983 名患者的数据。在每个地点,最有可能记录并达到孕前健康目标的指标是避免致畸药物(Site1 和 Site2 分别为 98.8%和 98.3%)和在孕早期进入护理(Site1 和 Site2 分别为 64.5%和 73.5%),而我们的叶酸使用、抑郁筛查和计划生育讨论的措施在两个地点的记录都不到 20%。我们研究中的两个医疗保健系统在衡量和记录 PCW 指标方面的差异,对监测和优化 PCW 构成了障碍。在怀孕前解决健康和健康问题的努力可能需要医疗保健系统和支付方使孕前健康指标标准化、纳入并推广,这些指标可以在医疗保健系统之间进行一致的衡量和分析。